We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Quiz Show Champion May Aid Clinical Diagnosis

By HospiMedica International staff writers
Posted on 20 Mar 2012
Supercomputer Watson may be able to apply the same technology it used to beat humans at trivia quizzes in a clinical setting, arriving at a diagnosis faster than a doctor can.

Watson--named after Thomas Watson, the first president of IBM (Armonk, NY, USA)--incorporates a technology called Deep Question and Answer (DeepQA) that allows it to analyze human language and quickly process huge amounts of information to come to an answer. More...
The same technology can also be applied to quickly process hundreds of diagnoses and potentially help treat patients. Watson can sift through an equivalent of about a million books or roughly, 200 million pages of data, analyze the information, and provide an answer in less than three seconds.

Unlike Google, Watson is not a search engine that presents the top most reliable answers. Instead, it homes in on the most important parts of a query and responds with an answer in the way a human brain would. For instance, if Watson is given the query: “This hormone deficiency is associated with Kallmann's syndrome,” it would rapidly locate a passage in medical literature that read, in part, “Isolated deficiency of GnRH or its receptor causes failure of normal pubertal development and amenorrhea in women. This disorder is termed Kallmann syndrome when it is accompanied by anosmia and has also been termed idiopathic hypogonadotropic hypogonadism.”

Rather than latching on to a random noun in that passage, such as amenorrhea or anosmia, Watson knows that GnRH refers to Gonadotropin-releasing hormone, so it selects it as the correct answer. Watson may also have future uses in helping to alert clinicians to adverse drug reactions, forming postoperative discharge and follow-up plans, and in managing chronic conditions. Watson’s capabilities were presented at the Healthcare Information and Management Systems Society (HIMSS) conference, held during March 2012 in Las Vegas (NV, USA).

“The average experienced clinician needs close to two million pieces of information to practice medicine, which they get in part from reading medical journals,” said Nick van Terheyden, MD, chief medical information officer at Nuance Communications (Burlington, MA, USA). “Doctors subscribe to an average of seven journals, which contain more than 2,500 new articles each year. It would require 80 hours of reading per week to keep up with all the newest medical literature.”

IBM and WellPoint (Indianapolis, IN, USA) announced a partnership in 2012 in which Wellpoint will use Watson technology to develop healthcare products to help aid in medical diagnosis.

Related Links:

IBM
Nuance Communications
WellPoint



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.